Financials Hyperfine, Inc.

Equities

HYPR

US44916K1060

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 02:00:01 27/04/2024 am IST 5-day change 1st Jan Change
0.845 USD +1.68% Intraday chart for Hyperfine, Inc. +1.81% -24.55%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 507.7 59.28 80.19 60.85 - -
Enterprise Value (EV) 1 507.7 59.28 80.19 60.85 60.85 60.85
P/E ratio -0.41 x -0.81 x -1.81 x -1.63 x -1.69 x -1.92 x
Yield - - - - - -
Capitalization / Revenue - 8.7 x 7.27 x 4.76 x 3.76 x 3.09 x
EV / Revenue - 8.7 x 7.27 x 4.76 x 3.76 x 3.09 x
EV / EBITDA - -0.95 x -1.89 x -1.5 x - -
EV / FCF - - -1.88 x -1.41 x -1.58 x -
FCF Yield - - -53.1% -70.8% -63.4% -
Price to Book - - - - - -
Nbr of stocks (in thousands) 70,032 70,576 71,600 72,008 - -
Reference price 2 7.250 0.8400 1.120 0.8450 0.8450 0.8450
Announcement Date 23/03/22 21/03/23 22/03/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 6.814 11.03 12.79 16.19 19.7
EBITDA 1 - -62.21 -42.32 -40.65 - -
EBIT 1 - -73.87 -48.12 -40.91 -37.62 -33.82
Operating Margin - -1,084.15% -436.14% -319.97% -232.4% -171.66%
Earnings before Tax (EBT) 1 - -73.16 -44.24 -37.35 -35.78 -31.98
Net income 1 -64.85 -73.16 -44.24 -37.35 -35.78 -31.98
Net margin - -1,073.73% -401% -292.1% -221% -162.29%
EPS 2 -17.57 -1.040 -0.6200 -0.5200 -0.5000 -0.4400
Free Cash Flow 1 - - -42.61 -43.05 -38.6 -
FCF margin - - -386.27% -336.68% -238.42% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 23/03/22 21/03/23 22/03/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 1.509 1.533 2.348 1.424 2.635 3.381 2.33 2.686 3.053 3.097 3.19 3.413
EBITDA 1 - - - -13.04 -11.58 -11.66 -10.3 -11.5 -10.08 -10.54 -10.08 -9.6 -9.62
EBIT 1 - -23.77 -23.19 -13.28 -13.63 -13.04 -11.69 -11.76 -11.63 -10.83 -10.37 -9.9 -9.95
Operating Margin - -1,575.28% -1,512.85% -565.67% -957.09% -494.69% -345.81% -504.68% -432.95% -354.69% -334.88% -310.34% -291.5%
Earnings before Tax (EBT) 1 - -23.78 -23.16 -13.17 -13.06 -12.16 -10.64 -10.76 -10.68 -9.91 -9.45 -8.97 -9.02
Net income 1 -16.39 -23.78 -23.16 -13.17 -13.06 -12.16 -10.64 -10.76 -10.68 -9.91 -9.45 -8.97 -9.02
Net margin - -1,575.55% -1,510.7% -560.95% -917.06% -461.48% -314.61% -461.67% -397.77% -324.56% -305.17% -281.19% -264.26%
EPS 2 -2.890 -0.3400 -0.3300 -0.1900 -0.1900 -0.1700 -0.1500 -0.1500 -0.1500 -0.1467 -0.1333 -0.1333 -0.1267
Dividend per Share - - - - - - - - - - - - -
Announcement Date 26/11/21 11/05/22 10/08/22 10/11/22 21/03/23 11/05/23 14/08/23 09/11/23 22/03/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - -42.6 -43.1 -38.6 -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - - 0.8 3.8 5.1 -
Capex / Sales - - 7.29% 29.72% 31.5% -
Announcement Date 23/03/22 21/03/23 22/03/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.845 USD
Average target price
1.3 USD
Spread / Average Target
+53.85%
Consensus
  1. Stock Market
  2. Equities
  3. HYPR Stock
  4. Financials Hyperfine, Inc.